GGrantIndex
Sort

16,300 grants matching fatty liver disease

Nuclear Receptors in Liver Health and Disease

$2,015,533
Hartmut W Jaeschke · University Of Kansas Medical Center · P20 · FY2014 · GM

Multi-Center Group to Study Acute Liver Failure in Child

$2,014,896
Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2005 · DK

UTRGV Diversity Center for Genome Research

$2,011,449
Sarah A. Williams-Blangero · University Of Texas Rio Grande Valley · U54 · FY2024 · HG

Impact of FGF21 on healthspan and lifespan

$2,011,300
Vishwa Deep Dixit · Yale University · P01 · FY2018 · AG

Development of Novel Therapies for NIDDM

$2,008,384
Christopher B Newgard · Duke University · P01 · FY2012 · DK

Functional Consequences of Impaired Autophagy in Aging

$2,002,853
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2011 · AG

Molecular signatures for liver cancer diagnosis and treatment stratification

$2,001,167
Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Impact of FGF21 on healthspan and lifespan

$1,997,502
Vishwa Deep Dixit · Yale University · P01 · FY2019 · AG

Xenobiotic receptors

$1,993,428
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,992,402
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA

Novel Mechanisms Regulating the Adipocyte-Brain-Hepatocyte Axis

$1,985,390
Philipp E Scherer · Ut Southwestern Medical Center · P01 · FY2016 · DK

Mechanisms of Atherogenesis in Insulin Resistance

$1,985,122
Ira A Tabas · Columbia University Health Sciences · P01 · FY2018 · HL

Impact of FGF21 on healthspan and lifespan

$1,983,293
Vishwa Deep Dixit · Yale University · P01 · FY2020 · AG

Development of TP-352 for the Treatment of Pediatric Non-alcoholic Steatohepatitis

$1,982,861
Frank Sciavolino · Thetis Pharmaceuticals, Llc · R44 · FY2020 · DK

UTRGV Center for Genome Research

$1,978,197
Sarah A. Williams-Blangero · University Of Texas Rio Grande Valley · U54 · FY2025 · HG

DEVELOPMENT OF NON-INVASIVE IMAGING PROBES FOR ASSESSING ALTERED MITOCHONDRIAL METABOLISM OF NON-ALCOHOLIC FATTY LIVER DISEASE

$1,978,071
The University Of Texas Southwestern Medical Center · · FY2022 · Defense Health Agency

Nuclear Receptors in Liver Health and Disease

$1,977,783
Hartmut W Jaeschke · University Of Kansas Medical Center · P20 · FY2015 · GM

Development of Novel Therapies for NIDDM

$1,966,913
Christopher B Newgard · Duke University · P01 · FY2014 · DK

Development of Novel Therapies for NIDDM

$1,966,913
Christopher B Newgard · Duke University · P01 · FY2016 · DK

Development of Novel Therapies for NIDDM

$1,966,913
Christopher B Newgard · Duke University · P01 · FY2015 · DK

Metabolism, infection and immunity in inborn errors of mitochondrial metabolism

$1,959,051
Peter McGuire · National Human Genome Research Institute · ZIA · FY2022 · HG

Novel Mechanisms Regulating the Adipocyte-Brain-Hepatocyte Axis

$1,958,638
Philipp E Scherer · Ut Southwestern Medical Center · P01 · FY2017 · DK

Framingham Heart Study/Fox

$1,956,697
Caroline Fox · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Regulation Of Intracellular Iron Metabolism

$1,948,600
Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Roles and Regulation of wild-type and mutant forms of p53

$1,945,587
Carol Prives · Columbia Univ New York Morningside · P01 · FY2017 · CA